Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 86651-86700 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05364996
Alveolar and Serum sRAGE in Severe Asthma in Children
N/ARecruiting
85 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT05673681
Spanish Academy of Dermatology and Venereology (AEDV) Melanoma Registry
N/ARecruiting
7,000 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2032
1 condition1 sponsor21 locations
NCT06680986
Echocardiographic Analysis by Artificial Intelligence in Hypertension
N/ARecruiting
200 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06136637
Monitoring of Glycocalyx for Prediction of Complications After Cardiac Surgery
N/ARecruiting
77 participants
Started: Jun 1, 2022 · Completed: Jul 1, 2026
1 condition2 sponsors1 location
NCT05290610
Intracranial Stimulation Mapping In Epilepsy
NARecruiting
30 participants
Started: Jun 1, 2022 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT06224322
Caregiver Burden in Cerebral Palsy Undergoing Hip and Knee Surgery
N/ARecruiting
45 participants
Started: Jun 1, 2022 · Completed: Sep 1, 2024
2 conditions1 sponsor2 locations
NCT05766449
Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD
N/ARecruiting
1,000 participants
Started: Jun 1, 2022 · Completed: May 1, 2027
2 conditions1 sponsor1 location
NCT05728801
Decoding the Cognitive Trajectory of Hong Kong SuperAgers: a Longitudinal Follow-up Study
N/ARecruiting
400 participants
Started: Jun 1, 2022 · Completed: Dec 1, 2024
3 conditions1 sponsor1 location
NCT05802251
Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study
N/ARecruiting
68 participants
Started: Jun 1, 2022 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT05513040
Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment
N/ARecruiting
300 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor4 locations
NCT05405270
Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
N/ARecruiting
410 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2026
4 conditions7 sponsors15 locations
NCT05366647
GATT Versus Canaloplasty (GVC)
NARecruiting
100 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2025
1 condition2 sponsors1 location
NCT06530290
Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients
PHASE2Recruiting
64 participants
Started: Jun 1, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06931613
Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment
PHASE2Enrolling by invitation
20 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2027
4 conditions1 sponsor2 locations
NCT05197972
Assessment of Cardiac Coherence Associated With Medical Hypnosis on Preoperative Anxiety in Oncological Surgery
NARecruiting
296 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor4 locations
NCT05558111
The Supraspinal Control of Lower Urinary Tract Function in Patients with Orthotopic Sigmoid Neobladder.
N/ARecruiting
40 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT05326399
Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment
N/ARecruiting
369 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor2 locations
NCT05441566
Significance of MRD After Surgery in Driver Gene-positive and Driver Gene-negative Stage IB-IIA NSCLC
N/AEnrolling by invitation
60 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05174052
Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
PHASE3Recruiting
28 participants
Started: Jun 1, 2022 · Completed: Apr 1, 2025
2 conditions1 sponsor1 location
NCT06235489
Evaluation of Clinical Success of Bulk Fil Composite Versus Highly Viscous Glass Ionomer in Primary Class II Molars
NARecruiting
150 participants
Started: Jun 1, 2022 · Completed: May 1, 2024
1 condition1 sponsor1 location
NCT06633094
Home Management of Pediatric Buckle Fractures
NAActive, not recruiting
46 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT05611684
The Influencing Factors of 12 Week Efficacy of Polyethylene Glycol Losenatide in Type 2 Diabetes Patients
PHASE4Recruiting
480 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04902703
Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease
PHASE2Recruiting
42 participants
Started: Jun 1, 2022 · Completed: Oct 31, 2027
1 condition4 sponsors1 location
NCT05604391
The Effect of Free Gingival Graft on Root Closure
NARecruiting
40 participants
Started: Jun 1, 2022 · Completed: Mar 15, 2026
2 conditions1 sponsor1 location
NCT05703217
C Mill Virtual Reality Applied Rehabilitation and Classical Rehabilitation on Gait and Balance in Parkinson's Patients
NAEnrolling by invitation
20 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2024
2 conditions2 sponsors1 location
NCT03935997
Implementing, Evaluating, and Scaling Up of the Strengthening a Palliative Approach in Long Term Care (SPA-LTC) Program
NAActive, not recruiting
594 participants
Started: Jun 1, 2022 · Completed: Jan 31, 2026
1 condition7 sponsors4 locations
NCT05112081
Evaluation of Botox Treatment on Chronical Scrotal Pain
PHASE4Not yet recruiting
50 participants
Started: Jun 1, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06499337
Safety Plan in Emergency Department to Prevent Suicidal Attempt Recidive
N/AActive, not recruiting
80 participants
Started: Jun 1, 2022 · Completed: Jul 31, 2024
4 conditions1 sponsor1 location
NCT05210764
General Anesthetics-related Changes in Prefrontal EEG During Pediatric Surgical Anesthesia
N/ARecruiting
366 participants
Started: Jun 1, 2022 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT05264025
Fexofenadine in Patients With Active Rheumatoid Arthritis
PHASE1/PHASE2Recruiting
80 participants
Started: Jun 1, 2022 · Completed: Jan 31, 2026
1 condition1 sponsor2 locations
NCT05276050
Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
NARecruiting
50 participants
Started: Jun 1, 2022 · Completed: Jun 30, 2027
3 conditions2 sponsors1 location
NCT05743257
How Urban Interventions in Lower Socioeconomic Areas Influence Health Behaviors (UrbASanté Study)
N/ARecruiting
400 participants
Started: Jun 1, 2022 · Completed: Jan 1, 2026
1 condition4 sponsors1 location
NCT05217693
A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors
PHASE1Recruiting
288 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor7 locations
NCT05369364
The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
PHASE2Not yet recruiting
150 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2026
1 condition6 sponsors0 locations
NCT05611983
Experience and Feasibility of Methods for Early Sensory Training
NARecruiting
60 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2024
2 conditions1 sponsor1 location
NCT05281237
Avecure Flexible Microwave Ablation Probe For Lung Nodules
NARecruiting
10 participants
Started: Jun 1, 2022 · Completed: Jun 30, 2027
6 conditions3 sponsors1 location
NCT05369377
Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia
PHASE2Not yet recruiting
150 participants
Started: Jun 1, 2022 · Completed: Dec 30, 2025
1 condition6 sponsors1 location
NCT05325177
PDA Treatment With Ibuprofen and Changes in Tissue Oxygenation.
PHASE4Recruiting
30 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05678413
Role of Paclitaxel in Stricture Urethra
NARecruiting
200 participants
Started: Jun 1, 2022 · Completed: Oct 1, 2025
1 condition1 sponsor1 location
NCT05133804
Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD
PHASE2Recruiting
53 participants
Started: Jun 1, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor3 locations
NCT05292001
Single-dose Intravenous Iron Therapy for Anemia After Orthopaedic Trauma
PHASE4Recruiting
150 participants
Started: Jun 1, 2022 · Completed: May 31, 2026
2 conditions3 sponsors1 location
NCT04904562
Angiotensin II for Distributive Shock
PHASE4Recruiting
40 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT06240169
Effect of Age on the Success of DPC Using Bio-ceramic Materials in Cariously Exposed Teeth With Reversible Pulpitis
NAActive, not recruiting
174 participants
Started: Jun 1, 2022 · Completed: Mar 30, 2024
1 condition1 sponsor1 location
NCT05687396
Virtual Reality in COPD Exacerbation
NARecruiting
50 participants
Started: Jun 1, 2022 · Completed: Apr 22, 2024
2 conditions1 sponsor1 location
NCT04903119
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
PHASE1Recruiting
30 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2029
2 conditions3 sponsors4 locations
NCT06718088
Risk Factors Associated With the Progression of Adenomyosis
N/ARecruiting
258 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT05206929
Prescribed Sternal Precautions vs. Self-Guided Restrictive Care (PEEERC)
NARecruiting
64 participants
Started: Jun 1, 2022 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT05331456
Alveolar Cleft Repair Using Osteoinductive Ceramics
NARecruiting
60 participants
Started: Jun 1, 2022 · Completed: Feb 1, 2025
3 conditions5 sponsors4 locations
NCT05379894
Modified Supine vs Prone Position Pnl
N/ARecruiting
200 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT05318222
Genetic Inclusion by Virtual Evaluation
NARecruiting
200 participants
Started: Jun 1, 2022 · Completed: Jan 31, 2027
3 conditions1 sponsor1 location